Joseph P. Lyssikatos serves as Executive at Enliven Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joseph P. Lyssikatos has executed 52 insider transactions totaling $5.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 29, 2023 involved selling 12,000 shares valued at $163.4K.
Joseph P. Lyssikatos currently holds 740,188 shares of Enliven Therapeutics, Inc. (ELVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph P. Lyssikatos has been a net seller of ELVN stock. They have purchased $0 and sold $5.0M worth of shares.
Joseph P. Lyssikatos's most recent insider trade was on Sep 29, 2023, when they sold 12,000 shares at $13.62 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |